Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators

Justin M. Scheer, Richard Vandlen(PDL BioPharma (United States))
PLoS ONE
December 20, 2012
Cited by 39


Related Papers

No related papers found

Powered by citation graph analysis